April 22, 2025
TOPLINE: Blood-based proteomic profiling of 251 inflammatory proteins in 543 newly diagnosed patients with acute myeloid leukemia (AML) identified an eight-protein signature that enhances risk stratification. […]
April 22, 2025
TOPLINE: Gut microbiome analysis of patients with multiple myeloma receiving idecabtagene vicleucel (ide-cel) therapy revealed specific bacterial species linked to treatment response and toxicity outcomes. Major […]
April 22, 2025
TOPLINE: Chronic lymphocytic leukemia (CLL) cell–derived exosomes demonstrated the ability to alter healthy donor cell function and suppress normal blood cell formation. These particles affected monocytes, […]
April 21, 2025
TOPLINE: Immune-related adverse events (irAEs) were associated with significantly improved progression-free survival (PFS) and overall survival (OS) in patients with extensive-stage small cell lung cancer (SCLC) […]
April 18, 2025
Incorporating a polygenic risk score into prostate cancer screening could enhance the detection of clinically significant prostate cancer that conventional screening may miss, according to results […]
April 17, 2025
Like a creature from a science fiction movie, chronic lymphocytic leukemia (CLL) can be a shape-shifter. In a small number of cases, patients with CLL will […]
April 16, 2025
With 200 patients treated, the Hospital Clínico San Carlos in Madrid, Spain, has launched Europe’s first Oncohaematological Immunoprevention Unit aimed at the early detection of immunodeficiencies […]
April 15, 2025
TOPLINE: Droplet digital polymerase chain reaction (PCR) measurements of circulating tumor DNA (ctDNA) identify patients with stage III melanoma who are at high risk for early […]
April 14, 2025
TOPLINE: CT examinations performed on 62 million patients in the United States during 2023 are projected to result in approximately 103,000 future cancer cases. Adults account […]